Prenatal Testing Market Prenatal Testing

DPI Research Offering Flat 30% off on All Research Reports on Year End.

Use Coupon Code : DPI30United States Non Invasive Prenatal Testing Market 2021 is an all-inclusive, proficient report provides an in-detail analysis of extensive drivers, challenges, restraints, opportunities, present market trends and approach influencing the NIPT industry together with projections and forecast to 2028.

The report additionally predicts future growth of The Non Invasive Prenatal Testing Market across the United States by integrating the information with relevant findings.Download Free Sample Report @ https://dpiresearch.com/request-a-free-sample-reportThe U.S. Non-Invasive Prenatal Testing market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods and ACOG guidelines recommend NIPT for all pregnancies regardless of risk.

The report also provides up–to–date historical market size data for the period 2015 – 2020 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in the United States.This Comprehensive Market Research Report Provides:To Analyse the Historical Growth in the Market Size of the United States Non–Invasive Prenatal Testing Market from 2015 to 2020.To Estimate and Forecast the Market Size of the United States Non–Invasive Prenatal Testing Market from 2021 to 2028 and Growth Rate until 2028.The Market Size of the United States Average Risk Non–Invasive Prenatal Testing Market with Seven Years ForecastThe Market Size of the United States High-Risk Non–Invasive Prenatal Testing Market with Seven Years ForecastEvaluates the Number of NIPT Tests Performed in the United States with Seven Years ForecastStudies the United States Number of Average Risk NIPT Tests Performed with Seven Years ForecastExamines the United States Number of High-Risk NIPT Tests Performed with Seven Years ForecastAssessment of Market Potential and Opportunities for this Innovation-Driven United States Non–Invasive Prenatal Testing Market with Seven Years ForecastInsights into the United States Average and High-Risk Potential NIPT Tests Market with Seven Years ForecastMeticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future TrendsAnalyses of the United States Average and High-Risk Potential Number of Tests Performed with Seven Years ForecastDetailed Insights into the Regulatory Framework of the United States Non–Invasive Prenatal Testing MarketFeatures Reimbursement Patterns of the United States Non–Invasive Prenatal Testing MarketTracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing AgreementA Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent DevelopmentEnquire for customization in Report @: https://dpiresearch.com/services/custom-research-services-providing-focused-comprehensive-tailored-research/The Leading Companies for the United States Non–Invasive Prenatal Testing Market are Listed Below:IlluminaNateraQuest DiagnosticsMyriad GeneticsCentogeneGenPathProgenityPerkinElmerYourgene HealthInvitae CorporationAgilent TechnologiesAriosa Diagnostics (Roche)Integrated Genetics (LabCorp)Key Questions Answered in this Report:What is the current scenario of the United States non–invasive prenatal testing market?What is the total market size and forecast (until 2028) for the United States non–invasive prenatal testing market?How has the potential market performed so far and how will it perform in the coming years?How many NIPT tests being performed in the U.S. during 2015 – 2028?What is the market size of the average risk NIPT tests in the United States?What is the market size of the high-risk NIPT tests in the United States?What are the key marketed NIPT tests available in the United States?What are the major drivers of the United States non–invasive prenatal testing market?What are the major inhibitors of the United States non–invasive prenatal testing market?What is the reimbursement pattern in the United States non–invasive prenatal testing market?What is the regulatory framework in the United States non–invasive prenatal testing market?What are the major deals and agreement happenings in the United States non–invasive prenatal testing market?Who are the top market players?

What are their happenings, current developments, and scenarios?How is the market predicted to develop in the future?For More Information@ https://dpiresearch.com/u-s-non-invasive-prenatal-testing-market-21/The report is readily available and can be dispatched immediately after payment confirmation.Would like to place an order or any question, please feel free to contact at sales@dpiresearch.comCustomization of the Report:DPI Research provides customization of the report as per your need.

Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.Contact Us:Maria RaiHead of Business DevelopmentDPI Research | Web: https://dpiresearch.comDirect Line: +91-766-764-8693E-mail: sales@dpiresearch.comAbout Us:DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals.

Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.

However, a dearth of skilled professionals is restraining the growth of this market.

[144 Pages Report] The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.

The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.Market DynamicsHigh Risk of Chromosomal Abnormalities With Increasing Maternal AgeGrowing Preference for Noninvasive Techniques Over Invasive MethodsImproving Reimbursement Scenario for NIPTPrograms Focusing on Increasing the Awareness of NIPTThe trisomy applications segment accounted for the largest share of the global NIPT market in 2018.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).

This segment is also estimated to grow at the highest CAGR during the forecast period.

The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.

Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.

However, a dearth of skilled professionals is restraining the growth of this market.According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690Growth prospects in Non Invasive Prenatal Testing (NIPT) Market :The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.

However, a dearth of skilled professionals is restraining the growth of this market.By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.

The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).

In 2018, trisomy was the largest application segment of the NIPT market.Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.

In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products.Inquire or share your questions if any before the purchasing this report: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=145607690Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).